Company / Free Cash Flow per Share
Edwards Lifesciences Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$2.30
FY2025
5-year range
$0.48 / $2.31
FY2021-FY2025
Trend
+376.7%
vs FY2024
Sector context
#65 of 148
Health Care
What the data says
Free Cash Flow per Share changed +377% YoY in FY2025, a notable deviation from the 9-year average annual change of +48%.
Based on SEC 10-K filings.
2.30 in FY2025 with a 5-year CAGR of +17.3%.
Remained stable around $2.30 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +12.8%
- 5-Year CAGR
- +17.3%
- 10-Year CAGR
- -
Sector benchmark
#65 of 148 in Health CareTop 44% of 148This company $2.30 Sector average $5.05
▼
-54.5% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 376.7% year-over-year.
- Ranks #65 out of 148 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2019.
- Lowest free cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.30 | +376.7% |
| FY2024 | $0.48 | -79.1% |
| FY2023 | $2.31 | +44.4% |
| FY2022 | $1.60 | -29.0% |
| FY2021 | $2.25 | +117.3% |
| FY2020 | $1.04 | -76.7% |
| FY2019 | $4.44 | +34.1% |
| FY2018 | $3.31 | -15.8% |
| FY2017 | $3.93 | +57.6% |
| FY2016 | $2.50 | -39.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026